These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25700025)

  • 1. Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.
    McCoy LE; Groppelli E; Blanchetot C; de Haard H; Verrips T; Rutten L; Weiss RA; Jolly C
    Retrovirology; 2014 Oct; 11():83. PubMed ID: 25700025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
    J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent.
    Reh L; Magnus C; Schanz M; Weber J; Uhr T; Rusert P; Trkola A
    PLoS Pathog; 2015 Jul; 11(7):e1004966. PubMed ID: 26158270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
    Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrapotent Broadly Neutralizing Human-llama Bispecific Antibodies against HIV-1.
    Xu J; Zhou T; McKee K; Zhang B; Liu C; Nazzari AF; Pegu A; Shen CH; Becker JE; Bender MF; Chan P; Changela A; Chaudhary R; Chen X; Einav T; Kwon YD; Lin BC; Louder MK; Merriam JS; Morano NC; O'Dell S; Olia AS; Rawi R; Roark RS; Stephens T; Teng IT; Tourtellott-Fogt E; Wang S; Yang ES; Shapiro L; Tsybovsky Y; Doria-Rose NA; Casellas R; Kwong PD
    Adv Sci (Weinh); 2024 Jul; 11(26):e2309268. PubMed ID: 38704686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization.
    McCoy LE; Quigley AF; Strokappe NM; Bulmer-Thomas B; Seaman MS; Mortier D; Rutten L; Chander N; Edwards CJ; Ketteler R; Davis D; Verrips T; Weiss RA
    J Exp Med; 2012 Jun; 209(6):1091-103. PubMed ID: 22641382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody.
    van Montfort T; Thomas AA; Krawczyk PM; Berkhout B; Sanders RW; Paxton WA
    J Immunol; 2015 Oct; 195(8):3759-68. PubMed ID: 26355155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies.
    Dufloo J; Bruel T; Schwartz O
    Retrovirology; 2018 Jul; 15(1):51. PubMed ID: 30055632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 binding site broadly neutralizing antibody selection of HIV-1 escape mutants.
    Dreja H; Pade C; Chen L; McKnight Á
    J Gen Virol; 2015 Jul; 96(Pt 7):1899-905. PubMed ID: 25762593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies.
    Ali A; Kitchen SG; Chen ISY; Ng HL; Zack JA; Yang OO
    J Virol; 2016 Aug; 90(15):6999-7006. PubMed ID: 27226366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.
    Su B; Peressin M; Ducloy C; Penichon J; Mayr LM; Laumond G; Schmidt S; Decoville T; Moog C
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1187-91. PubMed ID: 26252799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Env-2dCD4 S60C complexes act as super immunogens and elicit potent, broadly neutralizing antibodies against clinically relevant human immunodeficiency virus type 1 (HIV-1).
    Killick MA; Grant ML; Cerutti NM; Capovilla A; Papathanasopoulos MA
    Vaccine; 2015 Nov; 33(46):6298-306. PubMed ID: 26432912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission.
    Luo X; Mouquet H; Schwartz O; Greene WC
    J Biol Chem; 2021 Oct; 297(4):101098. PubMed ID: 34418431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding site.
    Zhou T; Chen L; Gorman J; Wang S; Kwon YD; Lin BC; Louder MK; Rawi R; Stancofski ED; Yang Y; Zhang B; Quigley AF; McCoy LE; Rutten L; Verrips T; Weiss RA; ; Doria-Rose NA; Shapiro L; Kwong PD
    Structure; 2022 Jun; 30(6):862-875.e4. PubMed ID: 35413243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evolution of broadly neutralizing Llama antibodies to the CD4-binding site of HIV-1.
    McCoy LE; Rutten L; Frampton D; Anderson I; Granger L; Bashford-Rogers R; Dekkers G; Strokappe NM; Seaman MS; Koh W; Grippo V; Kliche A; Verrips T; Kellam P; Fassati A; Weiss RA
    PLoS Pathog; 2014 Dec; 10(12):e1004552. PubMed ID: 25522326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV transmission from infected CD4+ T cells to allogenic T and dendritic cells is inhibited by broadly neutralizing antibodies.
    Ducloy C; Su B; Mayr L; Klingler J; Decoville T; Schmidt S; Laumond G; Salomé N; Bahram S; Moog C
    AIDS; 2018 Jun; 32(10):1239-1245. PubMed ID: 29683853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo protection by broadly neutralizing HIV antibodies.
    van Gils MJ; Sanders RW
    Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in a context-dependent manner.
    Patil S; Choudhary I; Chaudhary NK; Ringe R; Bansal M; Shukla BN; Boliar S; Chakrabarti BK; Bhattacharya J
    Virology; 2014 Aug; 462-463():266-72. PubMed ID: 24999839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.